Table 1 Patients demographic and baseline characteristics
Characteristics | No. (%) of patients | P-Value | |
|---|---|---|---|
Moxifloxacin (n = 40) | Control (n = 40) | ||
Age, mean (SD), year | 49.5 (19.8) | 45.8 (17.8) | 0.387 |
Women | 23 (57.5) | 17 (42.5) | 0.183 |
BMI, mean (SD), kg/m2 | 25.66 (3.72) | 26.31 (2.98) | 0.783 |
Concurrent comorbidities | |||
Hypertension | 4 (10.0) | 4 (10.0) | 0.110 |
Hypothyroidism | 3 (7.5) | 1 (2.5) | |
Migraine | 0 (0.0) | 2 (5.0) | |
Smoking, yes | 8 (20.0) | 10 (25.0) | 0.442 |
No. (%) of antibiotics category prescribed after surgery | |||
Cephalosporin | 30 (75.0) | 22 (55.0) | 0.197 |
Cephalosporin + nitroimidazole | 7 (17.5) | 9 (22.5) | |
Lincomycin + fluoroquinolone | 0 (0.0) | 2 (5.0) | |
Fluoroquinolone + nitroimidazole | 0 (0.0) | 1 (2.5) | |
Penicillin + Macrolides | 0 (0.0) | 1 (2.5) | |
Fluoroquinolone | 0 (0.0) | 1 (2.5) | |
Cephalosporin + Lincomycin | 1 (2.5) | 0 (0.0) | |
Lincomycin | 0 (0.0) | 1 (2.5) | |
Cephalosporin + Penicillin | 1 (2.5) | 1 (2.5) | |
fluoroquinolone + Lincomycin | 1 (2.5) | 1 (2.5) | |
macrolides + Nitroimidazole | 0 (0.0) | 1 (2.5) | |